MEDIPOST Co. Ltd
MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. It operates CELLTREE, an umbilical cord blood bank; and offers cord blood banking services to treat various incurable diseases. The company also markets CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthrit… Read more
MEDIPOST Co. Ltd (078160) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.054x
Based on the latest financial reports, MEDIPOST Co. Ltd (078160) has a cash flow conversion efficiency ratio of -0.054x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-14.44 Billion) by net assets (₩265.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MEDIPOST Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how MEDIPOST Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MEDIPOST Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDIPOST Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Incar Financial Service Co. Ltd.
KQ:211050
|
0.307x |
|
CITY OFFICE REIT DL -01
F:5QV
|
N/A |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
|
-0.063x |
|
Spok Holdings Inc
NASDAQ:SPOK
|
0.055x |
|
S.Biomedics Co. Ltd.
KQ:304360
|
-0.015x |
|
Infortrend Technology Inc
TW:2495
|
-0.012x |
|
Live Oak Acquisition Corp. V Class A Ordinary Shares
NASDAQ:LOKV
|
-0.001x |
|
Cubic Sensor and Instrument Co Ltd
SHG:688665
|
0.041x |
Annual Cash Flow Conversion Efficiency for MEDIPOST Co. Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of MEDIPOST Co. Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩252.60 Billion | ₩-37.27 Billion | -0.148x | -142.55% |
| 2023-12-31 | ₩313.66 Billion | ₩-19.08 Billion | -0.061x | -76.79% |
| 2022-12-31 | ₩179.97 Billion | ₩-6.19 Billion | -0.034x | -235.26% |
| 2021-12-31 | ₩159.48 Billion | ₩4.06 Billion | 0.025x | +66.11% |
| 2020-12-31 | ₩116.54 Billion | ₩1.78 Billion | 0.015x | -77.26% |
| 2019-12-31 | ₩111.59 Billion | ₩7.51 Billion | 0.067x | +23.88% |
| 2018-12-31 | ₩126.81 Billion | ₩6.89 Billion | 0.054x | +181.97% |
| 2017-12-31 | ₩104.45 Billion | ₩-6.93 Billion | -0.066x | +23.49% |
| 2016-12-31 | ₩143.31 Billion | ₩-12.42 Billion | -0.087x | -83.84% |
| 2015-12-31 | ₩146.48 Billion | ₩-6.91 Billion | -0.047x | -270.60% |
| 2014-12-31 | ₩117.34 Billion | ₩-1.49 Billion | -0.013x | -229.63% |
| 2011-12-31 | ₩115.04 Billion | ₩1.13 Billion | 0.010x | -- |